Anti KL-6 antibody enhances the effects of molecular targeted drug
Project/Area Number |
23659433
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Hiroshima University |
Principal Investigator |
KOHNO Nobuoki 広島大学, 医歯薬保健学研究院(医), 教授 (80215194)
|
Co-Investigator(Renkei-kenkyūsha) |
HATTORI Noboru 広島大学, 医歯薬保健学研究院(医), 准教授 (00283169)
ISHIKAWA Nobuhisa 広島大学, 医歯薬保健学研究院(医), 講師 (90423368)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2013: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | KL-6 / 分子標的治療薬 / 肺癌 |
Research Abstract |
The aim of the present study was to investigate the additive effect of anti-KL-6 antibody on the therapeutic antibody-induced ADCC (Antibody-Dependent Cellular-Cytotoxicity) activity. The expression of HER2 and KL-6 were measured using FACS analysis in 4 cancer cell lines (SK-BR-3, ZR75-1, PC3, YMB-S), and both HER2 and KL-6 were highly expressed in YMB-S cells. Accordingly, the effects of anti KL-6 antibody on the ADCC activity of PBMCs evoked by Trastuzumab were examined using Cr-51 release assay. Enhanced cytotoxicity was observed in an effector-to-target ratio manner when YMB-S cells were treated with anti-KL-6 antibody. These findings indicate that anti KL-6 antibody can enhance the therapeutic antibody-induced ADCC activity mediated by mononuclear cells.
|
Report
(4 results)
Research Products
(37 results)
-
-
[Journal Article] SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis2013
Author(s)
Masuda T, Hattori N, Senoo T, Akita S, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Kohno N
-
Journal Title
Mol Cancer Ther
Volume: 12
Pages: 2378-88
Related Report
Peer Reviewed
-
[Journal Article] SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.2013
Author(s)
Masuda T, Hattori N, Senoo T, Akita S, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Kohno N.
-
Journal Title
Mol Cancer Ther
Volume: 12
Issue: 11
Pages: 2378-88
DOI
Related Report
Peer Reviewed
-
[Journal Article] Characteristics of inspiratory and expiratory reactance in interstitial lung disease.2013
Author(s)
Sugiyama A, Hattori N, Haruta Y, Nakamura I, Nakagawa M, Miyamoto S, Onari Y, Iwamoto H, Ishikawa N, Fujitaka K, Murai H, Kohno N.
-
Journal Title
Respir Med
Volume: 107
Issue: 6
Pages: 875-82
DOI
Related Report
Peer Reviewed
-
[Journal Article] A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan.2013
Author(s)
Okamoto T, Miyazaki Y, Ogura T, Chida K, Kohno N, Kohno S, Taniguchi H, Akagawa S, Mochizuki Y, Yamauchi K, Takahashi H, Johkoh T, Homma S, Kishi K, Ikushima S, Konno S, Mishima M, Ohta K, Nishioka Y, Yoshimura N, Munakata M, Watanabe K, Miyashita Y, Inase N.
-
Journal Title
Respir Investig
Volume: 51
Pages: 191-199
Related Report
Peer Reviewed
-
[Journal Article] RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer.2013
Author(s)
Oshita H, Nishino R, Takano A, Fujitomo T, Aragaki M, Kato T, Akiyama H, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y.
-
Journal Title
Mol Cancer Res
Volume: 11
Issue: 8
Pages: 937-951
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Interferon (alpha, beta and omega) receptor 2 is a prognostic biomarker for lung cancer2012
Author(s)
Tanaka S, Hattori N, Ishikawa N, Horimasu Y, Deguchi N, Takano A, Tomoda Y, Yoshioka K, Fujitaka K, Arihiro K, Okada M, Yokoyama A, Kohno N
-
Journal Title
Pathobiology
Volume: 79
Issue: 1
Pages: 24-33
DOI
Related Report
Peer Reviewed
-
[Journal Article] Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels2012
Author(s)
Horimasu Y, Hattori N, Ishikawa N, K awase S, Tanaka S, Yoshioka K, Yokoy ama A, Kohno N, Bonella F, Guzman J, Ohshimo S, Costabel U
-
Journal Title
Respir Med
Volume: 106
Issue: 12
Pages: 1756-64
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Ethnic difference in the incidence of acute exacerbation in idiopathic pulmonary fibrosis2013
Author(s)
Ohshimo S, Ishikawa N, Horimasu Y, Fujitaka K, Haruta Y, Murai H, Hattori N, Bonella F, Kohno N, Guzman J, Costabel U.
Organizer
American Thoracic society international Conference 2013
Place of Presentation
フィラデルフィア、アメリカ
Related Report
-
-
-
[Presentation] MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.2013
Author(s)
Ohshimo S, Horimasu Y, Bonella F, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Hirohashi N, Hattori N, Tanigawa K, KohnoN, Guzman J, Costabel U.
Organizer
2013 European Respiratory Society Annual Congress
Place of Presentation
バルセロナ、スペイン
Related Report
-
-
-
-
-
-
-
[Presentation] Serum KL-6 is a useful diagnostic and prognostic biomarker in idiopathic interstitial pneumonia in German patients.2011
Author(s)
Horimasu Y, Ohshimo S, Ishikawa N, Tanaka S, Yoshioka K, Bonella F, Hattori N, Kohno N, Guzman J, Costabel U.
Organizer
American Thoracic Society International Conference
Place of Presentation
Denver, U.S.A.
Related Report
-
-
-
[Presentation] Serum SP-A and SP-D: different cutoff values for German and Japanese patients to diagnose idiopathic interstitial pneumonia.2011
Author(s)
Horimasu Y, Hattori N, Ishikawa N, Tanaka S, Yoshioka K, Ohshimo S, Bonella F, Guzman J, Costabel U, Kohno N.
Organizer
European Respiratory Society Annual Congress
Place of Presentation
Amsterdam, Netherlands
Related Report
-
-